There are more than 500 brokerages and research houses that hire analysts to issue ratings and recommendations. Collectively, these brokerages and their analysts publish approximately 250,000 ratings each year. Every trading day, there are nearly 700 reports and recommendations that are released to the public. To say that it's difficult to separate the signal from the noise when interpreting this data would be an understatement.
MarketBeat has developed a system to track each brokerage and research house's stock recommendations and score them based on their past performance. If Goldman Sachs predicted that Apple's stock price would hit $150.00 on a specific date, how accurate were they? If Bank of America issued a "strong-buy" rating on a stock, how did that stock perform compared to the broader market over the following twelve months? This tracking system has been applied to the 1,000,000+ ratings that MarketBeat has tracked during the last ten years to identify which brokerages you can really trust (and which you can safely ignore).
This slide show lists the 10 brokerages who have issued the most accurate analyst recommendations over the past several years, as measured by the performance of their "buy" ratings and the accuracy of their price targets.
#1 - Stifel Firstegy
- Average 12 Month ROI on "Buy" Recommendations
- 134.270%
- Based on
- 67 research note(s)
- MarketBeat Brokerage Ranking
- 5 of 5 stars
Recent Recommendations from Stifel Firstegy
- Pine Cliff Energy Ltd. (TSE: PNE) was downgraded by analysts at Stifel Firstegy from a "buy" rating to a "hold" rating. (7/13/2023)
- Gibson Energy Inc. (TSE: GEI) was upgraded by analysts at Stifel Firstegy from a "hold" rating to a "buy" rating. (5/16/2023)
- Gibson Energy Inc. (OTCMKTS: GBNXF) was upgraded by analysts at Stifel Firstegy from a "hold" rating to a "buy" rating. (5/16/2023)
- Gibson Energy Inc. (OTCMKTS: GBNXF) had its "hold" rating re-affirmed by analysts at Stifel Firstegy. (5/2/2023)
- Birchcliff Energy Ltd. (TSE: BIR) was downgraded by analysts at Stifel Firstegy from a "buy" rating to a "hold" rating. (3/16/2023)
#2 - Taglich Brothers
- Average 12 Month ROI on "Buy" Recommendations
- 109.318%
- Based on
- 15 research note(s)
- MarketBeat Brokerage Ranking
- 5 of 5 stars
Recent Recommendations from Taglich Brothers
- Cosmos Health Inc. (NASDAQ: COSM) had its "speculative buy" rating re-affirmed by analysts at Taglich Brothers. (2/20/2024)
- Super League Enterprise, Inc. (NASDAQ: SLE) had its "speculative buy" rating re-affirmed by analysts at Taglich Brothers. (9/5/2023)
- BioSig Technologies, Inc. (NASDAQ: BSGM) had its "speculative buy" rating re-affirmed by analysts at Taglich Brothers. (4/10/2023)
- DecisionPoint Systems, Inc. (NYSEARCA: DPSI) had its "speculative buy" rating re-affirmed by analysts at Taglich Brothers. (4/6/2023)
- Air Industries Group (NYSE: AIRI) had its "speculative buy" rating re-affirmed by analysts at Taglich Brothers. (4/6/2023)
#3 - Imperial Capital
- Average 12 Month ROI on "Buy" Recommendations
- 96.014%
- Based on
- 124 research note(s)
- MarketBeat Brokerage Ranking
- 5 of 5 stars
Recent Recommendations from Imperial Capital
- Hims & Hers Health, Inc. (NYSE: HIMS) was downgraded by analysts at Imperial Capital from an "outperform" rating to an "in-line" rating. (8/9/2024)
- Hims & Hers Health, Inc. (NYSE: HIMS) was upgraded by analysts at Imperial Capital from an "in-line" rating to an "outperform" rating. They now have a $16.00 price target on the stock. (2/28/2024)
- Whole Earth Brands, Inc. (NASDAQ: FREE) had its "neutral" rating re-affirmed by analysts at Imperial Capital. (2/14/2024)
- Napco Security Technologies, Inc. (NASDAQ: NSSC) was downgraded by analysts at Imperial Capital from an "outperform" rating to an "in-line" rating. They now have a $45.00 price target on the stock. (2/6/2024)
- Hims & Hers Health, Inc. (NYSE: HIMS) is now covered by analysts at Imperial Capital. They set an "inline" rating and a $9.00 price target on the stock. (12/7/2023)
#4 - National Securities
- Average 12 Month ROI on "Buy" Recommendations
- 86.982%
- Based on
- 77 research note(s)
- MarketBeat Brokerage Ranking
- 5 of 5 stars
Recent Recommendations from National Securities
- JOYY Inc. (NASDAQ: YY) had its "buy" rating re-affirmed by analysts at National Securities. They now have a $132.00 price target on the stock. (6/18/2021)
- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) is now covered by analysts at National Securities. They set a "buy" rating on the stock. (2/9/2021)
- Genprex, Inc. (NASDAQ: GNPX) is now covered by analysts at National Securities. They set a "buy" rating and a $280.00 price target on the stock. (1/26/2021)
- iHuman Inc. (NYSE: IH) is now covered by analysts at National Securities. They set a "buy" rating and a $26.10 price target on the stock. (12/24/2020)
- iQIYI, Inc. (NASDAQ: IQ) had its "buy" rating re-affirmed by analysts at National Securities. They now have a $23.20 price target on the stock. (12/24/2020)
#5 - Siebert Williams Shank
- Average 12 Month ROI on "Buy" Recommendations
- 75.433%
- Based on
- 46 research note(s)
- MarketBeat Brokerage Ranking
- 5 of 5 stars
Recent Recommendations from Siebert Williams Shank
- Otter Tail Co. (NASDAQ: OTTR) was upgraded by analysts at Siebert Williams Shank from a "strong sell" rating to a "hold" rating. (11/6/2024)
- MDU Resources Group, Inc. (NYSE: MDU) was upgraded by analysts at Siebert Williams Shank from a "hold" rating to a "buy" rating. They now have a $19.00 price target on the stock. (11/4/2024)
- Chord Energy Co. (NASDAQ: CHRD) was upgraded by analysts at Siebert Williams Shank to a "strong-buy" rating. (10/15/2024)
- Ovintiv Inc. (TSE: OVV) was upgraded by analysts at Siebert Williams Shank to a "strong-buy" rating. (10/15/2024)
- Ovintiv Inc. (NYSE: OVV) was upgraded by analysts at Siebert Williams Shank to a "strong-buy" rating. (10/15/2024)
#6 - Laurentian
- Average 12 Month ROI on "Buy" Recommendations
- 70.100%
- Based on
- 40 research note(s)
- MarketBeat Brokerage Ranking
- 5 of 5 stars
Recent Recommendations from Laurentian
- Altius Minerals Co. (TSE: ALS) had its price target raised by analysts at Laurentian from C$23.50 to C$23.75. (5/9/2024)
- Mainstreet Equity Corp. (TSE: MEQ) was given a new C$180.00 price target on by analysts at Laurentian. They now have a "buy" rating on the stock. (1/22/2024)
- Granite Real Estate Investment Trust (TSE: GRT.UN) had its price target raised by analysts at Laurentian from C$80.00 to C$90.00. They now have a "buy" rating on the stock. (1/22/2024)
- Boardwalk Real Estate Investment Trust (TSE: BEI.UN) had its price target raised by analysts at Laurentian from C$75.00 to C$80.00. (1/22/2024)
- Canadian Apartment Properties REIT (TSE: CAR.UN) was given a new C$55.00 price target on by analysts at Laurentian. They now have a "buy" rating on the stock. (1/22/2024)
#7 - R. F. Lafferty
- Average 12 Month ROI on "Buy" Recommendations
- 66.964%
- Based on
- 40 research note(s)
- MarketBeat Brokerage Ranking
- 5 of 5 stars
Recent Recommendations from R. F. Lafferty
- Lucid Group, Inc. (NASDAQ: LCID) was upgraded by analysts at R. F. Lafferty from a "hold" rating to a "buy" rating. They now have a $4.00 price target on the stock. (11/11/2024)
- GreenPower Motor Company Inc. (CVE: GPV) was upgraded by analysts at R. F. Lafferty to a "strong-buy" rating. (9/11/2024)
- GreenPower Motor Company Inc. (NASDAQ: GP) is now covered by analysts at R. F. Lafferty. They set a "buy" rating and a $3.00 price target on the stock. (9/11/2024)
- Canoo Inc. (NASDAQ: GOEV) was downgraded by analysts at R. F. Lafferty from a "buy" rating to a "hold" rating. (5/15/2024)
- Workhorse Group Inc. (NASDAQ: WKHS) had its "sell" rating re-affirmed by analysts at R. F. Lafferty. (3/13/2024)
#8 - Tudor Pickering & Holt
- Average 12 Month ROI on "Buy" Recommendations
- 64.019%
- Based on
- 237 research note(s)
- MarketBeat Brokerage Ranking
- 5 of 5 stars
Recent Recommendations from Tudor Pickering & Holt
- Pembina Pipeline Co. (TSE: PPL) had its price target raised by analysts at Tudor Pickering & Holt from C$55.00 to C$56.00. (7/5/2024)
- TC Energy Co. (TSE: TRP) had its price target raised by analysts at Tudor Pickering & Holt from C$63.00 to C$65.00. They now have a "hold" rating on the stock. (2/16/2022)
- Keyera Corp. (TSE: KEY) was given a new C$31.00 price target on by analysts at Tudor Pickering & Holt. They now have a "hold" rating on the stock. (2/16/2022)
- Whitecap Resources Inc. (TSE: WCP) was given a new C$10.50 price target on by analysts at Tudor Pickering & Holt. They now have a "buy" rating on the stock. (2/14/2022)
- Enbridge Inc. (TSE: ENB) was given a new C$53.00 price target on by analysts at Tudor Pickering & Holt. They now have a "hold" rating on the stock. (2/11/2022)
#9 - Tudor Pickering
- Average 12 Month ROI on "Buy" Recommendations
- 61.641%
- Based on
- 262 research note(s)
- MarketBeat Brokerage Ranking
- 5 of 5 stars
Recent Recommendations from Tudor Pickering
- CNX Resources Co. (NYSE: CNX) was upgraded by analysts at Tudor Pickering to a "strong sell" rating. (10/1/2024)
- Methanex Co. (TSE: MX) was upgraded by analysts at Tudor Pickering to a "strong-buy" rating. (9/11/2024)
- Marathon Petroleum Co. (NYSE: MPC) was downgraded by analysts at Tudor Pickering from a "strong-buy" rating to a "strong sell" rating. (9/9/2024)
- PBF Energy Inc. (NYSE: PBF) was upgraded by analysts at Tudor Pickering to a "strong sell" rating. (9/9/2024)
- CVR Energy, Inc. (NYSE: CVI) was upgraded by analysts at Tudor Pickering to a "strong sell" rating. (9/9/2024)
#10 - Piper Sandler Companies
- Average 12 Month ROI on "Buy" Recommendations
- 60.750%
- Based on
- 148 research note(s)
- MarketBeat Brokerage Ranking
- 5 of 5 stars
Recent Recommendations from Piper Sandler Companies
- Accenture plc (NYSE: ACN) had its "neutral" rating re-affirmed by analysts at Piper Sandler Companies. They now have a $329.00 price target on the stock. (9/20/2024)
- Abbott Laboratories (NYSE: ABT) is now covered by analysts at Piper Sandler Companies. They set an "overweight" rating and a $131.00 price target on the stock. (9/19/2024)
- Acrivon Therapeutics, Inc. (NASDAQ: ACRV) had its "buy" rating re-affirmed by analysts at Piper Sandler Companies. They now have a $30.00 price target on the stock. (9/6/2024)
- C3.ai, Inc. (NYSE: AI) had its "neutral" rating re-affirmed by analysts at Piper Sandler Companies. They now have a $24.00 price target on the stock. (9/5/2024)
- Aadi Bioscience, Inc. (NASDAQ: AADI) was downgraded by analysts at Piper Sandler Companies from an "overweight" rating to a "neutral" rating. They now have a $1.75 price target on the stock. (8/27/2024)
More Investing Slideshows:
